⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iv breast cancer

Every month we try and update this database with for stage iv breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerNCT00075764
Breast Cancer
anastrozole
fulvestrant
18 Years - SWOG Cancer Research Network
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsNCT00667641
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Melanoma (Skin)
Ovarian Cancer
Pancreatic Canc...
Prostate Cancer
Unspecified Adu...
bortezomib
paclitaxel
18 Years - Rutgers, The State University of New Jersey
Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast CancerNCT00238290
Breast Cancer
Trastuzumab + L...
18 Years - 120 YearsSwiss Group for Clinical Cancer Research
Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerNCT00003927
Breast Cancer
filgrastim
amifostine trih...
cyclophosphamid...
doxorubicin hyd...
paclitaxel
peripheral bloo...
18 Years - 59 YearsCity of Hope Medical Center
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyNCT01153672
Male Breast Can...
Recurrent Breas...
Stage IV Breast...
vorinostat
laboratory biom...
biopsy
F-18 16 alpha-f...
positron emissi...
anastrozole
letrozole
exemestane
gene expression...
18 Years - University of Washington
Chemotherapy in Treating Patients With Breast CancerNCT00012129
Breast Cancer
liposomal annam...
18 Years - 120 YearsNYU Langone Health
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsNCT00471432
Bladder Cancer
Breast Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Unspecified Adu...
custirsen sodiu...
docetaxel
pharmacological...
18 Years - 120 YearsCanadian Cancer Trials Group
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor TherapyNCT00688194
Breast Cancer
anastrozole
exemestane
fulvestrant
lapatinib ditos...
letrozole
placebo
18 Years - National Cancer Institute (NCI)
Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerNCT00006104
Breast Cancer
trastuzumab
docetaxel
18 Years - Vanderbilt-Ingram Cancer Center
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation TherapyNCT01487954
Radiation Toxic...
Recurrent Breas...
Stage I Breast ...
Stage II Breast...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Breast...
alkaline water
distilled water
external beam r...
18 Years - Case Comprehensive Cancer Center
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving EverolimusNCT02015559
Estrogen Recept...
HER2-negative B...
Oral Complicati...
Progesterone Re...
Recurrent Breas...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Breast...
mucoadhesive or...
laboratory biom...
18 Years - Jonsson Comprehensive Cancer Center
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerNCT00003536
Stage IV Breast...
Recurrent Breas...
antineoplaston ...
methotrexate
alternative pro...
biological ther...
biologically ba...
cancer preventi...
chemotherapy
complementary a...
differentiation...
- National Cancer Institute (NCI)
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticNCT00003440
HER2-negative B...
HER2-positive B...
Recurrent Breas...
Stage IIIC Brea...
Stage IV Breast...
paclitaxel
trastuzumab
quality-of-life...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Doxorubicin in Treating Women With Advanced Breast CancerNCT00003165
Breast Cancer
doxorubicin-HPM...
18 Years - National Cancer Institute (NCI)
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast CancerNCT00003066
Breast Cancer
docetaxel
estramustine ph...
18 Years - National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast CancerNCT01918306
Estrogen Recept...
Human Epidermal...
Triple Negative...
Recurrent Breas...
Stage IV Breast...
Triple-negative...
cisplatin
laboratory biom...
pharmacological...
dynamic contras...
GDC -0941
18 Years - Vanderbilt-Ingram Cancer Center
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionNCT00002901
Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerNCT04670445
Stage IV Melano...
Advanced Lung C...
Stage IV Non-Sm...
Unresectable No...
Unresectable St...
Small Cell Lung...
Stage IV Merkel...
Stage IV Cutane...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colore...
Stage IV Gastri...
Stage IV Esopha...
Stage IV Hepato...
Stage IV Renal ...
Stage IV Bladde...
Stage IV Head a...
Stage IV Cervic...
Stage IV Endome...
Stage IV Mesoth...
Immunotherapy
Immune Checkpoi...
Educational Vid...
Usual Care
18 Years - Massachusetts General Hospital
Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerNCT00039520
Breast Cancer
docetaxel
sulindac
18 Years - Fox Chase Cancer Center
Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By SurgeryNCT00305825
Breast Cancer
bevacizumab
letrozole
18 Years - 120 YearsUniversity of California, San Francisco
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer SurvivorsNCT01113554
Stage I Breast ...
Stage II Breast...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Breast...
questionnaire a...
exercise interv...
quality-of-life...
survey administ...
management of t...
psychosocial as...
18 Years - Wake Forest University Health Sciences
Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast CancerNCT00751101
Breast Cancer
Chemotherapeuti...
Palmar-plantar ...
Nicotine patch
18 Years - 75 YearsUniversity of California, San Francisco
Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast CancerNCT00020176
Breast Cancer
filgrastim
therapeutic all...
cyclophosphamid...
cyclosporine
fludarabine pho...
peripheral bloo...
18 Years - 70 YearsNational Cancer Institute (NCI)
GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/NeuNCT00085020
Breast Cancer
trastuzumab
lapatinib ditos...
18 Years - Jonsson Comprehensive Cancer Center
Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast CancerNCT00337233
Breast Cancer
Fatigue
Ovarian Cancer
Psychosocial Ef...
yoga therapy
18 Years - 120 YearsWake Forest University Health Sciences
Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast CancerNCT00002866
Breast Cancer
Neutropenia
filgrastim
docetaxel
epirubicin hydr...
16 Years - 120 YearsCanadian Cancer Trials Group
S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in RemissionNCT00227474
Breast Cancer
recombinant mod...
adjuvant therap...
recombinant vir...
18 Years - SWOG Cancer Research Network
Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast CancerNCT00006459
Breast Cancer
gemcitabine hyd...
paclitaxel
18 Years - Eli Lilly and Company
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast CancerNCT00003068
Breast Cancer
Drug/Agent Toxi...
amifostine trih...
cyclophosphamid...
mitoxantrone hy...
thiotepa
peripheral bloo...
16 Years - 70 YearsNational Cancer Institute (NCI)
ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast CancerNCT00404404
Breast Cancer
bevacizumab
paclitaxel albu...
18 Years - National Cancer Institute (NCI)
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast CancerNCT00005822
Breast Cancer
doxorubicin hyd...
semaxanib
conventional su...
radiation thera...
tamoxifen
18 Years - Case Comprehensive Cancer Center
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerNCT01706432
Central Nervous...
Invasive Ductal...
Invasive Ductal...
Invasive Lobula...
Invasive Lobula...
Liver Metastase...
Lobular Breast ...
Lung Metastases
Male Breast Can...
Medullary Ducta...
Mucinous Ductal...
Papillary Ducta...
Recurrent Breas...
Stage IV Breast...
Tubular Ductal ...
Tumors Metastat...
hyperfractionat...
laboratory biom...
stereotactic ra...
18 Years - University of Chicago
Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerNCT00006104
Breast Cancer
trastuzumab
docetaxel
18 Years - Vanderbilt-Ingram Cancer Center
ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast CancerNCT00404404
Breast Cancer
bevacizumab
paclitaxel albu...
18 Years - National Cancer Institute (NCI)
Phase II Dasatinib Study in Advanced Breast CancerNCT00546104
Advanced Breast...
Dasatinib
18 Years - Duke University
Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other ConditionsNCT00471601
Breast Cancer
counseling inte...
questionnaire a...
psychosocial as...
quality-of-life...
18 Years - 75 YearsMemorial Sloan Kettering Cancer Center
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the BoneNCT00301886
Breast Cancer
Hypercalcemia o...
Metastatic Canc...
Pain
ibandronate
zoledronate
quality-of-life...
18 Years - SWOG Cancer Research Network
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementNCT00869206
Breast Adenocar...
DS Stage I Plas...
DS Stage II Pla...
Metastatic Mali...
Pain
Musculoskeletal...
Urinary Complic...
zoledronic acid
18 Years - Alliance for Clinical Trials in Oncology
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryNCT02013492
Male Breast Can...
Recurrent Melan...
Stage IV Breast...
Stage IV Melano...
Stage IV Ovaria...
Stage IV Ovaria...
Unspecified Adu...
Hepatocellular ...
propranolol hyd...
Correlative Stu...
18 Years - Ohio State University Comprehensive Cancer Center
Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast CancerNCT00346229
Breast Cancer
filgrastim
pegfilgrastim
lyso-thermosens...
hyperthermia tr...
18 Years - Duke University
Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast CancerNCT00002680
Breast Cancer
filgrastim
cyclophosphamid...
megestrol aceta...
melphalan
tamoxifen citra...
thiotepa
conventional su...
peripheral bloo...
radiation thera...
18 Years - Yale University
Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsNCT02897375
Solid Neoplasm
Stage III Pancr...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Non-Sm...
Stage IVA Pancr...
Stage IVB Pancr...
Sarcoma
Colorectal Canc...
Head and Neck C...
Cancer of Unkno...
Bladder Cancer
Ovarian Cancer
Carboplatin
Cisplatin
Palbociclib
18 Years - Emory University
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticNCT00003440
HER2-negative B...
HER2-positive B...
Recurrent Breas...
Stage IIIC Brea...
Stage IV Breast...
paclitaxel
trastuzumab
quality-of-life...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast CancerNCT00998738
Neuropathy
Pain
Recurrent Breas...
Stage IV Breast...
Calcium Glucona...
Magnesium Sulfa...
Placebo
Quality-of-Life...
Questionnaire A...
Ixabepilone
18 Years - Mayo Clinic
Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2NCT00005635
Breast Cancer
trastuzumab
paclitaxel
18 Years - Genentech, Inc.
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast CancerNCT01385280
Estrogen Recept...
Progesterone Re...
Recurrent Breas...
Stage IIIC Brea...
Stage IV Breast...
therapeutic est...
exemestane
laboratory biom...
enzyme-linked i...
- University of Arizona
Biological Therapy in Treating Women With Breast Cancer That Has Spread to the LiverNCT00301106
Breast Cancer
Metastatic Canc...
adenovirus-medi...
18 Years - 85 YearsIcahn School of Medicine at Mount Sinai
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical CancerNCT00003135
Breast Cancer
Cervical Cancer
Endometrial Can...
Ovarian Cancer
fluorouracil
pegylated lipos...
hyperthermia tr...
18 Years - National Cancer Institute (NCI)
Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast CancerNCT00503906
Breast Cancer
Avastin
Gemcitabine
Abraxane
18 Years - 120 YearsUniversity of Miami
Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other ConditionsNCT00471601
Breast Cancer
counseling inte...
questionnaire a...
psychosocial as...
quality-of-life...
18 Years - 75 YearsMemorial Sloan Kettering Cancer Center
Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast CancerNCT00303992
Breast Cancer
trastuzumab
irinotecan hydr...
- 120 YearsUniversity of California, San Francisco
Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast CancerNCT00004013
Breast Cancer
trastuzumab
paclitaxel
- Fred Hutchinson Cancer Center
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsNCT01233505
Adenocarcinoma ...
Adenocarcinoma ...
BRCA1 Mutation ...
BRCA2 Mutation ...
Ovarian Mucinou...
Recurrent Breas...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Unspecified Adu...
veliparib
capecitabine
oxaliplatin
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic CancerNCT00898781
Breast Cancer
Colorectal Canc...
Ovarian Cancer
Pancreatic Canc...
- Mayo Clinic
Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast CancerNCT01009983
Breast Cancer
Recurrent Breas...
Stage IV Breast...
panitumumab
paclitaxel
carboplatin
laboratory biom...
immunohistochem...
18 Years - Wake Forest University Health Sciences
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast CancerNCT00899548
Breast Cancer
DNA methylation...
microarray anal...
polymerase chai...
laboratory biom...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast CancerNCT00376805
Breast Cancer
Fludarabine
Cyclophosphamid...
Total body irra...
Natural killer ...
Interleukin-2
18 Years - Masonic Cancer Center, University of Minnesota
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast CancerNCT00362973
Breast Cancer
laboratory biom...
needle biopsy
positron emissi...
radionuclide im...
fludeoxyglucose...
18 Years - 120 YearsUniversity of Washington
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast CancerNCT00006007
Breast Cancer
gemcitabine hyd...
pemetrexed diso...
18 Years - Alliance for Clinical Trials in Oncology
Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast CancerNCT00054275
Breast Cancer
docetaxel
erlotinib hydro...
18 Years - Case Comprehensive Cancer Center
Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerNCT00028483
Breast Cancer
cBR96-doxorubic...
docetaxel
18 Years - Seagen Inc.
Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast CancerNCT00080860
Breast Cancer
microarray anal...
immunohistochem...
conventional su...
lymphangiograph...
radionuclide im...
sentinel lymph ...
technetium Tc 9...
18 Years - National Institutes of Health Clinical Center (CC)
Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast CancerNCT00006120
Breast Cancer
docetaxel
paclitaxel
18 Years - 75 YearsNational Cancer Institute (NCI)
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast CancerNCT00266110
Breast Cancer
sargramostim
therapeutic aut...
trastuzumab
vinorelbine dit...
18 Years - UNC Lineberger Comprehensive Cancer Center
Strength and Range of Motion in Women Undergoing Surgery for Breast CancerNCT00489125
Breast Cancer
physiologic tes...
- 120 YearsWake Forest University Health Sciences
Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast CancerNCT00004013
Breast Cancer
trastuzumab
paclitaxel
- Fred Hutchinson Cancer Center
Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerNCT00054145
Breast Cancer
perifosine
18 Years - University Health Network, Toronto
Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast CancerNCT00075413
Breast Cancer
arsenic trioxid...
18 Years - 120 YearsThe University of Texas Medical Branch, Galveston
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsNCT02650635
Colorectal Aden...
Metastatic Panc...
Recurrent Breas...
Recurrent Color...
Recurrent Melan...
Recurrent Non-S...
Recurrent Pancr...
Recurrent Renal...
Solid Neoplasm
Stage IV Breast...
Stage IV Non-Sm...
Stage IV Renal ...
Stage IV Skin M...
Stage IVA Color...
Stage IVA Pancr...
Stage IVB Color...
Stage IVB Pancr...
Cyclophosphamid...
Laboratory Biom...
Pegfilgrastim
Pharmacological...
TLR8 Agonist VT...
18 Years - Mayo Clinic
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryNCT01705340
Adenocarcinoma ...
HER2-positive B...
Male Breast Can...
Recurrent Breas...
Recurrent Esoph...
Recurrent Gastr...
Stage IIIC Brea...
Stage IIIC Esop...
Stage IIIC Gast...
Stage IV Breast...
Stage IV Esopha...
Stage IV Gastri...
Akt inhibitor M...
trastuzumab
lapatinib ditos...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast CancerNCT00088829
Breast Cancer
paclitaxel
microarray anal...
biopsy
neoadjuvant the...
Paclitaxel
18 Years - Georgetown University
Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer PatientsNCT00317603
Breast Cancer
Autologous, Let...
18 Years - Dana-Farber Cancer Institute
Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast CancerNCT00066378
Breast Cancer
anastrozole
gefitinib
- European Organisation for Research and Treatment of Cancer - EORTC
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementNCT00869206
Breast Adenocar...
DS Stage I Plas...
DS Stage II Pla...
Metastatic Mali...
Pain
Musculoskeletal...
Urinary Complic...
zoledronic acid
18 Years - Alliance for Clinical Trials in Oncology
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast CancerNCT00424164
Breast Cancer
lapatinib ditos...
tamoxifen citra...
pharmacological...
18 Years - 120 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast CancerNCT00379509
Breast Cancer
lapatinib ditos...
TdT-mediated dU...
gene expression...
microarray anal...
immunohistochem...
biopsy
radiation thera...
18 Years - 120 YearsUNC Lineberger Comprehensive Cancer Center
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerNCT01938833
HER2-negative B...
Inflammatory Br...
Male Breast Can...
Recurrent Breas...
Stage IV Breast...
Romidepsin
Abraxane
18 Years - Thomas Jefferson University
3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast CancerNCT00095888
Male Breast Can...
Recurrent Breas...
Stage IV Breast...
triapine
gemcitabine hyd...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast CancerNCT00834678
Breast Cancer
bendamustine
erlotinib
Maintenance erl...
18 Years - Ohio State University Comprehensive Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: